Table 1.
Clinical Characteristics of Patients with Klebsiella pneumonia Infection
| Patient | Age | Sex | Specimen | Collection Date | Department | Immunosuppression | Antibiotic Agent Exposure | Intubation | HAI | Type of Infection | APACHE II >16 |
SOFA ≥6 |
CCI | Outcome in 30 Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Z1 | 78 | M | Sputum | 20171218 | Respiratory-N | N | Y | Y | Y | VAP | Y | Y | 6 | Survive |
| Z3 | 60 | M | Sputum | 20180101 | Respiratory-H | Y | Y | Y | Y | Pneumonia | Y | Y | 3 | Survive |
| Z4 | 48 | M | Tissue | 20180103 | Respiratory-H | Y | Y | Y | Y | Pneumonia | Y | Y | 4 | Survive |
| Z5 | 73 | F | Urine | 20180104 | Gastroenterology-H | N | Y | Y | Y | UTI | Y | N | 3 | Death** |
| Z6 | 37 | M | BALF | 20180104 | Respiratory-H | N | Y | Y | Y | VAP | N | Y | 1 | Survive |
| Z7 | 87 | M | Sputum | 20180108 | SICU | Y | Y | Y | Y | VAP | Y | Y | 4 | Survive |
| Z9 | 57 | F | Tissue | 20180112 | Respiratory-H | Y | Y | N | Y | Pneumonia | N | N | 3 | Survive |
| Z10 | 35 | M | Sputum | 20180115 | Internal Medicine | N | Y | Y | Y | VAP | N | N | 3 | Survive |
| Z12 | 80 | M | Sputum | 20180121 | Respiratory-N | Y | Y | Y | Y | Pneumonia | Y | Y | 6 | Survive |
| Z13 | 82 | F | Sputum | 20180122 | Respiratory-N | N | Y | Y | Y | Pneumonia | N | Y | 3 | Survive |
| Z14 | 44 | F | BALF | 20180122 | Respiratory-H | Y | Y | Y | Y | VAP | N | Y | 1 | Death |
| Z15 | 87 | F | Urine | 20180201 | Respiratory-N | N | Y | N | Y | CAUTI | Y | Y | 4 | Survive |
| Z17 | 42 | F | Drainage liquid | 20180208 | SICU | Y | Y | Y | Y | Pneumonia | N | Y | 4 | Death |
| Z18 | 35 | M | BALF | 20180211 | Respiratory-H | Y | Y | Y | Y | VAP | Y | Y | 4 | Death |
| Z19 | 80 | M | Sputum | 20180213 | SICU | Y | Y | Y | Y | VAP | Y | Y | 14 | Death |
| Z20 | 28 | M | Sputum | 20180224 | Respiratory-H | Y | Y | Y | Y | VAP | N | N | 1 | Death** |
| Z21 | 84 | F | Sputum | 20180218 | Respiratory-H | N | Y | N | CAI | Pneumonia | N | N | 1 | Survive |
| Z22 | 87 | F | Urine | 20180221 | Respiratory-N | N | Y | Y | Y | CAUTI | Y | Y | 4 | Death |
| Z23 | 81 | M | Urine | 20180222 | Nephrology-N | Y | Y | Y | Y | CAUTI | Y | Y | 4 | Death |
| Z24 | 86 | F | Urine | 20180224 | General Medicine-N | N | Y | Y | Y | UTI | Y | N | 5 | Survive |
| Z25 | 83 | F | Sputum | 20180309 | SICU | Y | Y | Y | Y | Pneumonia | Y | Y | 5 | Survive |
| Z26 | 70 | F | Sputum | 20180310 | Respiratory-N | Y | Y | Y | Y | VAP | Y | Y | 5 | Death |
| Z27 | 68 | M | Sputum | 20180315 | SICU | N | Y | Y | Y | VAP | Y | Y | 2 | Death |
| Z28 | 35 | M | Sputum | 20180317 | Neurology-N | Y | Y | Y | Y | Pneumonia | Y | N | 2 | Survive |
| Z29 | 76 | M | BALF | 20180417 | Respiratory-H | Y | Y | Y | Y | VAP | Y | N | 6 | Survive |
| Z31 | 58 | F | BALF | 20180427 | Respiratory-N | N | Y | Y | Y | Pneumonia | N | N | 2 | Death |
| Z32 | 28 | F | Blood | 20170618 | Respiratory-N | Y | Y | Y | Y | BSI | Y | Y | 4 | Death |
| Z33 | 58 | M | Sputum | 20180517 | Respiratory-H | Y | Y | Y | Y | VAP | Y | N | 3 | Survive |
| Z35 | 78 | F | BALF | 20180529 | Respiratory-H | N | Y | Y | Y | VAP | Y | Y | 2 | Death |
| Z36 | 78 | M | Sputum | 20180614 | Respiratory-N | N | Y | Y | Y | Pneumonia | Y | Y | 4 | Death** |
| Z37 | 78 | F | BALF | 20180617 | Respiratory-H | N | Y | Y | CAI | VAP | N | Y | 6 | Death |
| Z38 | 57 | F | Urine | 20180618 | CCU | N | Y | Y | Y | CAUTI | Y | Y | 5 | Survive |
| Z39 | 90 | F | Sputum | 20180110 | Respiratory-N | N | Y | Y | Y | Pneumonia | N | Y | 4 | Survive |
Note: **Withheld life-sustainable treatment; The -H and -N department means headquarters and north campus, respectively.
Abbreviations: CAI, community-acquired infection; HAI, hospital-acquired infection; BALF, bronchoalveolar lavage fluid; CAUTI, catheter-associated urinary tract infection; VAP, ventilator-associated pneumonia; BSI, bloodstream infection; UTI, urinary tract infection; SICU, surgery intensive care medicine; CCU, cardiac intensive care unit. Y, yes; N, no.